arrow_back Back to App

Combating illicit fentanyl trafficking and streamlining research.

New regulations aim to curb illicit trafficking of fentanyl-related substances by classifying them as dangerous drugs. Simultaneously, the act introduces changes to facilitate scientific research on these substances, potentially accelerating the development of new medicines and therapies. For citizens, this means potentially greater safety through reduced access to illegal substances and faster progress in medicine.
Key points
More fentanyl-related substances will be classified as illegal drugs, making their black market production and sale more difficult.
Rules for scientists conducting research on controlled substances have been simplified, potentially speeding up medical discoveries.
Government agencies will review research registration processes to reduce bureaucracy and increase efficiency.
article Official text account_balance Process page
Expired
Citizen Poll
No votes cast
Additional Information
Print number: 117_HR_2041
Sponsor: Rep. Luetkemeyer, Blaine [R-MO-3]
Process start date: 2021-03-18
Lustra uses Artificial Intelligence. Verify details in source documents.
Summarized by: gemini-2.5-flash-preview-05-20
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

SIFT Act of 2021

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_2041.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2021-03-18.

What are the main provisions?

Key points include:

  • More fentanyl-related substances will be classified as illegal drugs, making their black market production and sale more difficult.
  • Rules for scientists conducting research on controlled substances have been simplified, potentially speeding up medical discoveries.
  • Government agencies will review research registration processes to reduce bureaucracy and increase efficiency.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Luetkemeyer, Blaine [R-MO-3].

What is the latest detailed status?

The latest detailed status is: Referred to the Subcommittee on Crime, Terrorism, and Homeland Security.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2025-12-27.

CATEGORIES

Security Health Courts and Law